Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMahidol University

About this trial

Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.

Eligibility criteria

Qualifiers

Age >,= 18 years

Patients undergoing elective gynecologic-oncology surgery

Disqualifiers

Unable to communicate Thai

Unable to understand the questionnaire

Preexisting neuromuscular disease

Preexisting disease involved wrist that may affect the nerve stimulator examination

Trial design

Treatments tested in this trial

  • Train of four nerve stimulator

Treatment groups

622 Participants
are divided into 1 treatment group

Sponsors and collaborators